HR 241, the Sergeant Ted Grubbs Mental Healthcare for Disabled Veterans Act, requires the Department of Veterans Affairs to provide mental healthcare services within five days for veterans with service-connected mental disorders rated at 50% or higher. This bill directly affects disabled veterans whose mental health conditions are linked to military service and meet the 50% rating threshold. The key provision amends VA care standards to mandate timely access, ensuring these veterans receive hospital care, medical services, or extended care for their mental disorder no later than five days after requesting it. The law focuses on reducing wait times for a specific group of veterans with significant service-connected mental health needs.
This resolution (HRES 666) recognizes Overdose Awareness Day and commits the House to advancing bipartisan policies that reduce stigma around substance use disorders. It pledges collaboration with states, health providers, and communities to support prevention, treatment, harm reduction, and recovery efforts for opioid use disorder. As a non-binding resolution, it does not create new laws or allocate funds but expresses congressional support for existing crisis response strategies.
This bill removes immigration status barriers to health care for lawfully present immigrants and those with Federally authorized presence (like deferred action). It requires states to cover all lawfully present individuals in Medicaid and CHIP, expands ACA exchange eligibility for undocumented people with authorized presence, and allows states to opt into covering undocumented children in CHIP. Key provisions amend the Social Security Act to eliminate citizenship requirements for Medicaid/CHIP and treat Federally authorized presence as equivalent to lawfully present for ACA subsidies. The bill does not automatically cover all undocumented people but creates a state option to extend coverage to undocumented individuals meeting income criteria.
This bill establishes the Military-Civilian Medical Surge Program, requiring the Department of Defense (DoD) and Health and Human Services (HHS) to partner with civilian healthcare providers at eight or more strategic U.S. locations (including transport hubs and logistics centers) to rapidly deploy medical support during national emergencies. It directly affects military medical facilities and civilian healthcare systems by enhancing coordination for responding to crises like wars, pandemics, or disasters declared under specific federal laws. Key provisions mandate pre-identified partnerships with hospitals and academic medical centers that demonstrate expertise in high-consequence health threats, and require semiannual coordination meetings between DoD, HHS, and military health agencies. The program aims to strengthen the National Disaster Medical System’s capacity to mobilize civilian medical personnel to support military health operations during emergencies.
This bill creates new criminal and civil penalties for corporate entities whose actions contribute to patient harm in healthcare settings. It targets "covered parties" including executives, directors, shareholders, and private equity firms that receive "covered compensation" (such as salaries, bonuses, or equity) from a healthcare organization experiencing a "triggering event" like financial distress leading to patient harm. The bill establishes a clawback mechanism allowing the Attorney General or state attorneys general to recover compensation received by these entities during the 10 years before or after the triggering event, with recovered funds to be used for employee benefits or community health services. It also requires healthcare entities to report ownership information and mandates a study on profit-driven practices in healthcare delivery.
S 1399, the Health Tech Investment Act, creates a new Medicare payment category for algorithm-based healthcare services (like AI tools used in diagnosis or treatment) starting January 1, 2026. It requires Medicare to pay based on manufacturer costs (including software, staff, and overhead) and protects these services in the special payment category for at least five years, preventing reassignment without sufficient claims data. This directly affects Medicare beneficiaries receiving these AI-driven services and healthcare technology companies developing them. The bill also codifies existing Medicare payment rules for software-as-a-service starting January 1, 2023.
HRES 382 creates a procedural rule in the House of Representatives during the 119th Congress (2025-2026) to block budget reconciliation bills that cut Medicaid or SNAP benefits for specific vulnerable groups. It prohibits consideration of any reconciliation measure reducing benefits for children under 19, seniors 65+, pregnant women, or people with disabilities (as defined by Social Security law). The rule does not apply to provisions targeting fraud, improper payments, or improving eligibility verification. This resolution is a procedural tool, not a law, and would prevent such benefit cuts from advancing through the budget process.
HRES 256 designates March 2025 as Endometriosis Awareness Month, recognizing endometriosis as a common chronic condition affecting approximately 1 in 10 women of reproductive age. The resolution supports raising public awareness, promoting early detection and culturally competent care for those with the disease, and encourages increased research funding for better treatments and a potential cure. It specifically highlights the significant impacts of endometriosis, including diagnostic delays (3-11 years), chronic pain, high healthcare costs ($13,000+ annually per patient), and reduced workforce participation. This non-binding resolution directly affects women and girls living with endometriosis and aims to foster public education and support through designated awareness activities.
HRES 601 is a non-binding House resolution recognizing the Federal Government's duty to lead global biomedical research. It expresses Congress's position that NIH funding and scientific independence are critical national assets, emphasizing the need to protect research capacity and double biomedical investment over the next decade. The resolution lists specific goals, including reducing cancer deaths, advancing Alzheimer's research, and improving clinical trial representation, but does not create new laws or allocate funds. It directly addresses the National Institutes of Health (NIH), federal research policy, and the broader biomedical research community. As a symbolic resolution, it has no legal effect but aims to shape future policy discussions.
HR 6197, the Health Tech Investment Act, establishes a new payment category under Medicare for algorithm-based healthcare services (like AI tools used in diagnosis or treatment) starting January 1, 2026. It requires Medicare to pay based on manufacturer-provided costs (including software, staff, and overhead) for these services and prohibits removing them from the special payment category for at least five years after initial payment. This directly affects Medicare beneficiaries (through coverage), healthcare providers (who deliver these services), and AI/algorithm service manufacturers (who receive reimbursement). The bill ensures these new technologies get fair payment while gathering sufficient claims data before potentially moving them to standard payment categories.
